hPB10(Mapp Biopharmaceutical Inc)

N/A

Report date: 2023/01/04 19:56:14

Base Information

Drug NamehPB10(Mapp Biopharmaceutical Inc)
Drug Alias NamePB10 IgG1hPB-10
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPoisoning
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPoisoning
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A